Hydrite

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hydrite

Quick Facts

Property Description
Active Ingredients Glucose, Sodium Chloride, Potassium Chloride, and Citrate/Bicarbonate
Form Oral Powder (for reconstitution)
Pharmacological Class Electrolyte Replacement Agent / Fluid and Electrolyte Balancer
General Purpose Restoration of water balance and electrolyte replenishment
Origin Synthetic combination

What Type of Medicine is Hydrite?

Hydrite is a commercially recognized brand of Oral Rehydration Salt (ORS) formulation, which is a Combination Drug formally classified as an Electrolyte Replacement Agent and Fluid and Electrolyte Balancer. This essential medicine is most commonly provided as an Oral Powder that requires mixing with water to create an oral solution for consumption. It operates within the category of Oral Rehydration Therapy (ORT), a non-invasive approach designed to manage the acute loss of water and necessary salts from the body. The fundamental concept of ORS formulations is recognized as a core strategy for fluid management. The formula is clinically recognized for its capacity to restore physiological balance rapidly.

What is Hydrite Composed of, and Why?

The formulation of Hydrite is comprised of four primary constituents: the essential electrolytes Sodium Chloride and Potassium Chloride, an alkalizing agent such as Sodium Bicarbonate or Trisodium Citrate Dihydrate, and the carbohydrate Glucose (Dextrose). These components are typically synthetic in origin, ensuring reliable purity and concentration. These oral rehydration salts are mixtures of salt and sugar that help the body replace lost fluids and minerals. This means the combination of ingredients is effective at keeping the body's internal fluid balance stable. The efficacy relies critically on the presence of Glucose, which is required to facilitate the intestinal absorption of Sodium and subsequently, water.

What is the General Purpose of Hydrite?

The primary purpose of Hydrite is the restoration of water balance and efficient electrolyte replenishment to counteract the effects of rapid fluid loss, such as in the context of a temporary gastrointestinal illness. By utilizing the specialized Sodium-Glucose cotransport pathway, the preparation ensures that both water and essential salts are drawn directly into the bloodstream. This core physiological action prevents the severe consequences of depletion, such as hypovolemia, and helps stabilize the body’s internal fluid environment, making the formulation a critical and highly accessible method for non-invasive fluid management.

What side effects are possible with Hydrite?

Possible Side Effects and Safety Information

The safety profile for Oral Rehydration Salt (ORS) formulations, such as Hydrite, is primarily characterized by the low incidence of adverse reactions when the solution is prepared and used correctly, as outlined in official regulatory documents from authorities like the FDA and EMA.


Adverse Reaction Classification

Side effects are classified by the physiological system they affect and their frequency:

  • Gastrointestinal Disorders: The most commonly reported events are non-serious, including nausea, vomiting, abdominal cramps, and a sensation of abdominal fullness.
  • Metabolism and Nutrition Disorders: Serious safety concerns relate to fluid and electrolyte disturbances, such as hypernatremia (excess sodium). These severe reactions are typically documented as risks associated with improper preparation or use under contraindicated conditions, and their frequency is not known under correct administration.

Serious Adverse Risks and Limitations

Official labeling highlights the risk of Serious Fluid and Electrolyte Abnormalities, Cardiac Arrhythmias, and Seizures as potential consequences of severe imbalance, generally resulting from misuse (e.g., incorrect dilution) or pre-existing conditions.

The safety profile dictates specific restrictions and limitations for use:

  • Contraindications: The solution should not be used in individuals with conditions such as Gastrointestinal (GI) obstruction, Toxic Megacolon, Ileus, or Severe Renal Impairment.
  • Population Cautions: Use in patients with severe renal impairment or Diabetes requires medical supervision due to the critical impact on electrolyte and glucose metabolism. Use during pregnancy or lactation is generally considered acceptable but may require medical oversight.

The core safety constraint is the absolute requirement for correct dilution; improper preparation is the primary factor that increases the risk of documented serious adverse reactions.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of an Oral Rehydration Salt (ORS) formulation, such as Hydrite, is primarily defined by the acute effects of its active ingredients—sodium, potassium, and glucose—as documented in government regulatory materials. The overdose profile is focused on severe disturbances in fluid and electrolyte balance.

Documented Manifestations and Risks

Domain Official Regulatory Statements
Documented Manifestations Overdose may present with signs of severe electrolyte imbalance, including hypernatraemia (excess sodium) and hyperkalaemia (excess potassium). Other manifestations include hyperglycaemia, hypervolaemia (fluid overload), and neurological symptoms such as headache, confusion, and seizures.
Severe Outcomes The documented risks include cardiac arrhythmias, potential cardiac arrest (linked to hyperkalaemia), and acute hyponatraemic encephalopathy or irreversible brain injury due to severe fluid shifts.
Population-Specific Notes Children and patients with renal insufficiency are documented as being at a particular risk for severe, life-threatening complications.

Required Emergency Actions

Seek immediate medical attention for suspected overdose. Immediate professional medical help is required when symptoms suggest severe toxicity or life-threatening conditions. The officially documented management involves symptomatic and supportive treatment and requires close clinical monitoring of fluid balance, serum electrolytes, and glucose in a supervised setting.

Therapeutic Uses of Hydrite

Restoring Fluid and Electrolyte Balance

Hydrite, an Oral Rehydration Solution (ORS), is applied across domains where additional symptomatic support is needed for the management of dehydration caused by fluid loss. ORS may be part of symptomatic management for dehydration associated with diarrheal illness. It is commonly used for conditions presenting with acute episodes and systemic imbalance symptoms, primarily including acute diarrhea and vomiting, which are conditions marked by increased physiological stress. The core benefit contributes to easing the overall symptom load and supports the body during periods of heightened systemic burden.


Managing Symptoms & Supporting Stability

This medicine is commonly used when short-term symptomatic assistance is needed to help address symptom clusters that may become intense or disruptive. It helps manage the symptoms related to systemic imbalance and is applied in clinical settings that involve acute or unstable symptom patterns. It provides support that helps ease the overall symptom burden and assists with maintaining functional stability.


Key Uses

Hydrite is relevant in contexts marked by increased discomfort or tension associated with sudden fluid loss. This application is used during phases when symptoms become more noticeable and may help patients cope more steadily with difficult episodes. It offers symptomatic relief in conditions involving episodic or fluctuating manifestations.

Quick Fact: Support During Symptomatic Episodes Hydrite is applied in addressing symptoms related to systemic imbalance, contributing to improved comfort during periods of heightened symptoms.

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Hydrite

Official regulatory guidelines define the population eligibility for Hydrite (Oral Rehydration Salts/ORS) based on the patient's age and clinical status.

Category Official Regulatory Statement
Populations for whom use is allowed Infants and Children (all ages), Adults, and the Elderly are approved populations for the treatment of mild to moderate dehydration [3.1, 1.7].
Contraindicated Populations Use is contraindicated in patients with glucose malabsorption or known hypersensitivity to any component (e.g., glucose, salts) [1.5, 2.2].
Individuals with intestinal obstruction (ileus) or who are unconscious are also prohibited from use due to the risk of aspiration or inability to absorb the solution [1.7, 1.3].
Age-related Eligibility Status The medicine is considered established for use in all age groups, including infants; no contraindication is noted for use during pregnancy or while breastfeeding [1.5, 3.3].
Eligibility-Related Restrictions Severe dehydration is a clinical status that prohibits initial treatment with ORS alone, as urgent intravenous fluid replacement is required [1.4, 1.7]. Use in patients with renal disease (kidney impairment) or diabetes mellitus requires careful medical supervision and close monitoring of electrolyte and glucose levels [1.7, 2.3].

Connection to the overall eligibility profile

Regulatory documents structure eligibility by first establishing absolute contraindications linked to absorption (glucose malabsorption) or immediate physical risk (intestinal obstruction, unconsciousness). The profile is otherwise broadly permissive for all standard age groups while imposing conditional use requirements for patients with pre-existing metabolic or organ conditions where strict monitoring is required.

What should I know about interactions with other medicines?

Hydrite Interactions with other medicines and products

This section summarizes the officially documented interaction patterns for Hydrite (Oral Rehydration Salts, ORS) based on regulatory information. The primary documented interaction relates to the potassium component of the formula and its effect on electrolyte balance.


Documented Interactions with Medicinal Products

Pharmacodynamic Interaction Risk

Hydrite's potassium chloride content contributes an additive load of potassium. Co-administration with certain drug classes that reduce potassium excretion carries an increased risk of hyperkalemia (elevated serum potassium levels). This caution applies to:

  • ACE Inhibitors (Angiotensin-Converting Enzyme Inhibitors)
  • ARBs (Angiotensin II Receptor Blockers)
  • Potassium-Sparing Diuretics (e.g., Spironolactone)

Interactions with Food, Drinks, and Other Products

Regulatory restrictions focus on the preparation of the solution, as altering the concentration compromises therapeutic action. The powder must not be reconstituted with the following products:

  • Milk, Fruit Juice, or Carbonated Beverages: These liquids disrupt the formula's critical sodium-to-glucose ratio and osmotic balance.
  • Extra Sugar or Salt: Adding these components is strictly prohibited as it alters the necessary electrolyte balance required for effective rehydration.

Population-Specific Cautions

Official documents note that the hyperkalemia risk associated with co-administering Hydrite and potassium-retaining drugs is increased in severity in patients who have severe renal impairment (compromised kidney function).

Mechanism of Action

Specific Sodium and Water Cotransport

The action of Hydrite is a specific, non-pharmacological mechanism focused on leveraging the body's natural transport processes to increase net absorption of water and solutes. The foundational action occurs in the small intestine through the specialized carrier protein, Sodium-Glucose Cotransporter 1 ( SGLT1). The presence of D-Glucose is the necessary cotransport partner, as it obligatorily facilitates the simultaneous, coupled transport of Na^+ ions from the gut lumen into the intestinal cells. This direct molecular interaction initiates the entire solute transport cascade.

Osmotic Gradient and Physiological Regulation

The successful cotransport of Na^+ and D-Glucose establishes a powerful osmotic pressure gradient across the intestinal wall. This gradient acts as the driving force, causing net absorption of water to move passively from the gut into the systemic circulation. The resulting influx of fluid and balanced electrolytes ( K^+, Cl^-), along with the action of the alkalizing agent (Citrate/Bicarbonate), results in an expansion of the effective circulating volume and contributes to the regulation of systemic acid-base status.

Dosage and Administration Information

How to Use Hydrite: Administration Guidelines

Hydrite, an Oral Rehydration Salt (ORS) formulation, is intended strictly for oral administration using an event-driven dosing schedule to replace fluids and electrolytes lost due to acute illness. The administration protocol centers on precise preparation and proportional volume replacement.


Administration Scope

Field Instruction
Route of Administration For oral administration only.
Dosing Schedule (Adults) Dosing is event-driven and non-fixed. Adults should administer 200 mL to 400 mL of the solution after each loose stool or fluid loss event.
Preparation Requirements One sachet of powder must be dissolved completely in 200 mL of clean drinking water, preferably cooled boiled water. The mixed solution must not be boiled.
Age-Group Rules Children 2–10 years: Administer 100 mL to 200 mL after each loose stool. Infants < 2 years: Administer 50 mL to 100 mL after each loose stool.
Special Conditions If vomiting occurs, pause administration for 10 minutes, then resume at a slower rate (frequent, small amounts). The prepared solution must be discarded after 24 hours.

Procedural Structure

The protocol defines a usage sequence where the solution is administered only upon the occurrence of fluid loss, and its use continues until the symptomatic event ceases. This procedural structure is defined by the requirement to replace specific fluid volumes lost with a precisely measured oral solution to maintain physiological balance.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Hydrite


Evidence for Use in Acute Diarrhea and Dehydration Management

The research base for Oral Rehydration Solutions (ORS), a category which includes Hydrite, primarily involves Randomized Controlled Trials (RCTs) and Systematic Reviews and Meta-analyses. This body of evidence is relevant in trials assessing short-term or episodic symptom patterns related to fluid loss from acute diarrhea and gastroenteritis.

Research has primarily examined how ORS administration relates to the measurement of changes in clinical signs of dehydration, such as changes in body weight and vital signs. Studies monitored outcomes describing episodic or acute changes, specifically the frequency and volume of stool output and the duration of diarrhea. Studies reported patterns related to the need for unscheduled intravenous (IV) fluid therapy, which serves as a clinical measure of whether oral rehydration was used for the attainment of rehydration markers in the acute phase. In community-based observational settings, evidence also describes patterns related to measured mortality and hospitalization rates following the broad implementation of ORS programs.

The Role of Comparator Trials

Studies explored the use of ORS against other rehydration methods, mainly intravenous fluid administration. In short-term RCTs, ORS was observed in studies monitoring outcomes related to systemic or functional imbalance. These trials reported patterns indicating that ORS can be associated with similar rates of attainment of rehydration markers at defined time intervals compared to IV fluids, and some studies recorded a shorter time for therapy administration.

What is Still Uncertain About Hydrite

The research structure notes that the results apply only to the populations studied (primarily those with mild to moderate fluid loss). There is limited information for long-term outcomes or durability of the effect after the initial symptoms subside. Furthermore, the performance observed in clinical trials is sensitive to the solution's precise concentration, and research notes that suboptimal home preparation and variance in dilution is a factor that can affect the final concentration and performance of the solution outside of controlled trial settings.

Key Studies & References

  1. Evidence-based practice in paediatric gastroenterology. Part I: Acute gastroenteritis
  2. Oral fluid therapy for paediatric gastroenteritis: A systematic review and meta-analysis

Frequently Asked Questions (FAQ)

Common questions about Hydrite (FAQ)

Q: What are the most common side effects I should know about?

Official regulatory documents generally describe the most common events as non-serious gastrointestinal disturbances. These reported events include feelings of abdominal fullness, abdominal cramps, nausea, and vomiting.

Q: What happens if I stop taking Hydrite suddenly?

Since the administration of this solution is event-driven, its use is intended to continue until the symptoms of fluid loss, such as acute diarrhea, have naturally ceased. Regulatory guidance structures the use to stop when the clinical need for rehydration is resolved.

Q: Is Hydrite considered a controlled substance?

According to official regulatory schedules, Hydrite, which is an Oral Rehydration Salt formulation, is not listed as a controlled substance. This classification is due to its composition of salts and glucose, which are used for electrolyte balancing.

Q: Does Hydrite cause dependence or withdrawal symptoms?

Official documents do not describe or note any risk of dependence or withdrawal symptoms associated with the use of this solution. The product works by replacing lost fluid and electrolytes, not through a pharmacological action on the central nervous system.

Q: Are there any specific foods I should avoid when taking Hydrite?

While the powder must be mixed only with clean water for proper reconstitution, general official guidance suggests that appropriate feeding or a normal diet can often be resumed soon after treatment begins. Mixing the powder with foods or drinks other than water must be avoided, as this disrupts the necessary balance of ingredients.

Q: Will Hydrite still work if I miss a dose?

Since administration is event-driven (after each fluid loss event), there is no formally defined 'missed dose' instruction in the regulatory documentation, as the medicine is taken only when needed.

Q: Does Hydrite cause fatigue or drowsiness?

Official regulatory documents and safety profiles do not list fatigue or drowsiness among the reported side effects. These types of effects are typically associated with medicines that act on the central nervous system.

Q: Can Hydrite affect my mood or sleep?

The official labeling does not include mood changes or sleep disturbances among the documented adverse reactions. Its primary action is focused on correcting fluid and electrolyte imbalances in the body.

Q: What is the risk of having a serious interaction if I take Hydrite with alcohol?

Official drug interaction sections do not list a specific pharmacological interaction between the solution and alcohol. Consuming alcohol can, however, contribute to further dehydration, which is the condition the solution is intended to manage.

Q: Is it true that Hydrite can cause weight gain?

Weight gain beyond the restoration of fluid and electrolytes lost due to dehydration is not listed as a reported adverse reaction in the regulatory documents. The primary intended effect involves restoring the body's natural fluid balance.

Q: Does Hydrite have any reported sexual side effects?

Official regulatory information does not list any sexual side effects or adverse reactions. The safety profile focuses on risks related to fluid and electrolyte balance.

Q: Can I take pain relievers like ibuprofen or Tylenol while on Hydrite?

Official interaction documents do not list common over-the-counter pain relievers, such as NSAIDs or paracetamol, as having a known interaction with the solution. The main interactions noted involve medicines that affect potassium levels.

Q: Is it normal to have a headache in the first week of taking Hydrite?

Headache is not listed among the reported adverse reactions in official safety information. If a headache occurs, it is not described as a typical side effect of the solution itself.

Q: What are the criteria for a person to be considered eligible to use Hydrite?

The solution is broadly approved for use in all age groups, including infants, children, adults, and the elderly. Use is restricted (contraindicated) only for individuals with certain pre-existing conditions, such as severe renal impairment, intestinal obstruction, or known hypersensitivity to any of the solution’s components.

Q: Can I still drive or operate machinery while taking Hydrite?

The product labeling does not include a specific warning regarding the operation of machinery or driving ability. This is consistent with the fact that the solution is not associated with central nervous system side effects like drowsiness.

Q: What are the least common side effects of Hydrite that I might still experience?

The least common and most serious documented events typically involve risks related to severe fluid and electrolyte abnormalities. These serious risks, such as cardiac arrhythmias or seizures, are primarily associated with incorrect preparation or use under contraindicated conditions, and their frequency is not known under correct use.

Q: Does Hydrite interfere with birth control or other hormonal medications?

Official interaction summaries do not list any interference with birth control or other hormonal medications. The known interactions relate primarily to medicines that impact the body's potassium balance.

Q: Do older adults (seniors) need a different safety profile when taking Hydrite?

Official documents do not define a separate safety profile for the elderly, as the solution is approved for use across all age groups. However, the standard caution regarding pre-existing severe renal impairment applies to all adults, including seniors.

Q: What kind of tests or monitoring might be needed while taking Hydrite?

Close medical monitoring of electrolyte and glucose levels is specifically required for patients who have pre-existing severe renal impairment or diabetes. For otherwise healthy individuals using the solution for acute dehydration, regulatory documents typically do not mandate specific monitoring.

Q: Can Hydrite be taken at the same time as my other daily medications?

The official interaction sections focus on the potential for increased potassium levels with certain drug classes, such as ACE inhibitors. They do not specify or forbid the administration timing relative to other daily medications; the focus is on avoiding known drug-to-drug interactions.

Q: Is it possible to be allergic to an ingredient in Hydrite?

Official documentation states that use is contraindicated in individuals with known hypersensitivity to any component of the solution, which includes the glucose and salts. This acknowledges the possibility of an allergic reaction to an ingredient.

Q: Are there any known long-term risks associated with Hydrite?

Regulatory research summaries note that there is limited available information regarding the long-term outcomes or durability of the effects after the acute phase of treatment. The solution is primarily studied and intended for short-term use to resolve acute fluid loss.

Q: What is the consensus on Hydrite's use for people with pre-existing heart conditions?

The safety profile includes a serious warning regarding the risk of Cardiac Arrhythmias (irregular heart rhythms) as a potential consequence of severe fluid and electrolyte imbalance. The safety information notes this potential risk associated with severe electrolyte imbalance, which is a consideration for individuals with pre-existing heart conditions.

Q: Can Hydrite cause a skin rash or other visible reactions?

Official adverse reaction sections do not list skin rash or other dermatological reactions among the reported side effects. However, hypersensitivity (which can manifest as a rash) is listed as a general contraindication.

Q: Does age influence how well Hydrite works?

The solution is approved for use in all age groups, with specific administration volumes provided for infants, children, and adults. Its efficacy is based on the use of these age-appropriate preparation volumes.

Q: What if I forget to take Hydrite for a few days?

If fluid loss continues and the solution is not administered over a period of time, the patient risks uncorrected electrolyte abnormalities and worsening of dehydration symptoms. Its use is tied directly to the continuation of fluid loss events.

Q: Can I take Hydrite with antacids or acid reducers?

The solution contains an alkalizing agent (Citrate or Bicarbonate). Co-administration with other alkalizing agents, such as some antacids, may carry an increased risk of systemic alkalosis (a potentially problematic rise in body pH).

How should Hydrite be stored and disposed of?

How to Store and Dispose of Hydrite (Oral Rehydration Salts)

Hydrite powder must be stored at controlled room temperature, generally not exceeding 30°C (86°F), and should be kept out of the reach of children. The dry product must be protected from moisture and kept in its original, sealed packaging until use.

Handling and Stability

Once the powder is mixed with water, the reconstituted solution must not be frozen. Regulatory guidance mandates that the prepared solution must be discarded after 24 hours if stored in a refrigerator. Any solution left at room temperature should be discarded sooner.

Disposal

Do not flush unused or expired Hydrite down the sink or toilet. Disposal should follow local regulatory requirements, often requiring return to a drug take-back program or mixing with an undesirable substance (e.g., coffee grounds) and sealing it before placing it in the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Hydrite found in:

A-Z Index: